Cabozantinib in patients with locally advanced or metastatic urothelial cell carcinoma who have progressed after cisplatin-based chemotherapy and anti-PD-1/PD-L1 therapy or after anti-PD-1/PD-L1 therapy only.

被引：0

作者：

Bartsch, Georg

Thomas, Christian

Tsaur, Igor

Schnabel, Marco

Haferkamp, Axel

Gorbulev, Stanislav

Ruckes, Christian

Kronfeld, Kai

机构：

[1] Markus Krankenhaus, Frankfurt, Germany

[2] Natl Ctr Tumor Dis, Heidelberg, Germany

[3] Johannes Gutenberg Univ Mainz, Dept Urol & Pediat Urol, Mainz, Germany

[4] Univ Regensburg, Dept Urol, Caritas St Josef Med Ctr, Regensburg, Germany

[5] Univ Med Mainz, Mainz, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

525

引用

页数：1